Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Teva Pharmaceutical Industries Ltd (TEVA)

2015-02-27@15:18:59 ET
Teva Pharmaceutical (TEVA) Showing Bearish Technicals With Support At $56.14 (FBM)

2015-02-27@08:30:11 ET
Teva Announces Early Results of Debt Tender Offer, Pricing, Election of Early Settlement and Increase in Maximum Amount and Priority 2 Notes Tender Cap (BIZ)

2015-02-27@07:01:17 ET
Metastatic Pancreatic Cancer Pipeline Review 2015 - Analysis of 46 Companies & 66 DRug Profiles (MTO)

2015-02-27@07:01:07 ET
Growth Hormone Deficiency Pipeline Review 2015 - 22 Drug Profiles & 22 Companies (MTO)

2015-02-27@01:56:35 ET
Teva Releases Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study (CLM)

2015-02-26@08:35:00 ET
Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed (PRN)

2015-02-26@08:25:52 ET
Teva Pharmaceutical (TEVA) Showing Support Near $55.95 (FBM)

2015-02-26@08:00:06 ET
Teva to Present at the Cowen & Company 35th Annual Healthcare Conference (BIZ)

2015-02-26@06:50:22 ET
Global Autism Therapeutics Pipeline Review 2015 - 23 Companies & 35 Drug Profiles (MTO)

2015-02-26@05:24:35 ET
Global Optic Neuritis Clinical Trials Review 2015 (MTO)

2015-02-26@01:37:00 ET
Teva Cites Publication of Data from Phase III Trials of Reslizumab (CLM)

2015-02-25@08:00:07 ET
Teva Announces FDA Acceptance for Review of NDA for its Investigational Twice-Daily Hydrocodone Bitartrate Extended-Release Tablets with Proprietary Abuse Deterrence Technology (BIZ)

2015-02-25@06:00:53 ET
Teva announces positive results from Phase IIb chronic migraine study (DTM)

2015-02-24@10:51:42 ET
Chemotherapy Induced Neutropenia Therapeutics Pipeline Review, H1 2015 - Analysis of 22 Companies & 17 Drug Profiles (MTO)

2015-02-24@10:48:29 ET
Teva Pharmaceutical (TEVA) Showing Support Near $55.98 (FBM)

2015-02-24@10:40:27 ET
Fatigue Therapeutics Pipeline Review, H1 2015 - Analysis of 7 Companies (MTO)

2015-02-24@09:00:04 ET
Teva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary Endpoints (BIZ)

2015-02-23@15:23:43 ET
Teva Pharmaceutical (TEVA) Trading Near $55.82 Support Level (FBM)

2015-02-23@15:00:00 ET
The Lancet Respiratory Medicine and AAAAI Publish Positive Data from Phase III Trials of Teva's Reslizumab for the Treatment of Moderate to Severe Asthma in Patients with Elevated Blood Eosinophils (BIZ)

2015-02-23@12:13:08 ET
Teva Pharmaceutical Industries Bullish Moving Average Crossover Alert (TEVA) (F78)